Why the medical community is thrilled by U.S. support for a 'breakthrough' HIV drug

A vial of lenacapavir, the new HIV prevention injectable drug that only needs to be administered twice yearly but provides almost complete protection.

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of effort will be a model for how it does global health work in the future.

(Image credit: Nardus Engelbrecht)